Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-02-18 @ 7:05 PM
Study NCT ID:
NCT00097851
Status:
COMPLETED
Last Update Posted:
2022-06-27
First Post:
2004-11-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
Sponsor:
Cellxpert Biotechnology Corp.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PR88202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |